drugset
drugset / Trial / NCT03612921

Oral Amantadine, IV Amantadine and Hemodynamic Response to Laryngoscopy

NCT03612921 ↗

Phase 2 Unknown 60 enrolled Assiut University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

this study will be undertaken-to evaluate the effect of oral amantadine versus IV amantadine premedication on the hemodynamic response to laryngoscopy ,tracheal intubation and surgical incision and their effect on β-endorphins.

Timeline

Start
2018-08-15
Primary completion
2022-03-01
Completion
2022-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amantadine Unknown 100 mg Oral

Indications

No indication recorded.